rs61735631

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_002227.4(JAK1):​c.1516C>T​(p.Arg506Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000625 in 1,614,062 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R506H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00062 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00062 ( 2 hom. )

Consequence

JAK1
NM_002227.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2O:1

Conservation

PhyloP100: 0.792

Publications

15 publications found
Variant links:
Genes affected
JAK1 (HGNC:6190): (Janus kinase 1) This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2020]
JAK1 Gene-Disease associations (from GenCC):
  • autoinflammation, immune dysregulation, and eosinophilia
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.022575617).
BP6
Variant 1-64855641-G-A is Benign according to our data. Variant chr1-64855641-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 134541.
BS2
High AC in GnomAd4 at 95 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002227.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
NM_002227.4
MANE Select
c.1516C>Tp.Arg506Cys
missense
Exon 11 of 25NP_002218.2P23458
JAK1
NM_001320923.2
c.1516C>Tp.Arg506Cys
missense
Exon 12 of 26NP_001307852.1P23458
JAK1
NM_001321852.2
c.1516C>Tp.Arg506Cys
missense
Exon 11 of 25NP_001308781.1P23458

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
ENST00000342505.5
TSL:5 MANE Select
c.1516C>Tp.Arg506Cys
missense
Exon 11 of 25ENSP00000343204.4P23458
JAK1
ENST00000671929.2
c.1516C>Tp.Arg506Cys
missense
Exon 12 of 26ENSP00000500485.1P23458
JAK1
ENST00000671954.2
c.1516C>Tp.Arg506Cys
missense
Exon 12 of 26ENSP00000500841.1P23458

Frequencies

GnomAD3 genomes
AF:
0.000631
AC:
96
AN:
152124
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000754
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000663
AC:
165
AN:
249038
AF XY:
0.000666
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.000894
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.000510
Gnomad NFE exome
AF:
0.00119
Gnomad OTH exome
AF:
0.000661
GnomAD4 exome
AF:
0.000625
AC:
913
AN:
1461820
Hom.:
2
Cov.:
31
AF XY:
0.000723
AC XY:
526
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.000291
AC:
13
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00111
AC:
29
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86246
European-Finnish (FIN)
AF:
0.000562
AC:
30
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000719
AC:
799
AN:
1111960
Other (OTH)
AF:
0.000613
AC:
37
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
49
98
148
197
246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000624
AC:
95
AN:
152242
Hom.:
1
Cov.:
32
AF XY:
0.000712
AC XY:
53
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41520
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.000754
AC:
8
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00118
AC:
80
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00101
Hom.:
2
Bravo
AF:
0.000578
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00144
AC:
12
ExAC
AF:
0.000637
AC:
77
EpiCase
AF:
0.00136
EpiControl
AF:
0.00107

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Autoinflammation, immune dysregulation, and eosinophilia (2)
-
-
2
not provided (2)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.68
T
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.023
T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.79
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.10
Sift
Benign
0.053
T
Sift4G
Uncertain
0.051
T
Polyphen
0.66
P
Vest4
0.058
MVP
0.48
MPC
1.1
ClinPred
0.050
T
GERP RS
-0.030
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.64
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61735631; hg19: chr1-65321324; COSMIC: COSV61089402; COSMIC: COSV61089402; API